Search

Author/Creator Kirschfink, M.

1. [OP.LB.02.05] A PATIENT WITH MALIGNANT HYPERTENSION SUCCESSFULLY TREATED WITH ECULIZUMAB AND BOSENTAN - SUGGESTIONS OF SIGNIFICANT INTERACTIONS OF COMPLEMENT AND THE ENDOTHELIN SYSTEM IN BLOOD PRESSURE CONTROL. (September 2016)

Authors:
Mitchell, A.; Nokay, B.; Guberina, H.; Behlen-Wilm, U.; Nagel, M.; Kirschfink, M.; Wiech, T.; Kribben, A.; Bienholz, A.
Journal:
Journal of hypertension
Issue:
Volume 34:(2016) Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Monitoring of complement activation biomarkers and eculizumab in complement‐mediated renal disorders. (25th November 2016)

Authors:
Wehling, C.; Amon, O.; Bommer, M.; Hoppe, B.; Kentouche, K.; Schalk, G.; Weimer, R.; Wiesener, M.; Hohenstein, B.; Tönshoff, B.; Büscher, R.; Fehrenbach, H.; Gök, Ö.‐N.; Kirschfink, M.
Journal:
Clinical and experimental immunology
Issue:
Volume 187:Number 2(2017:Feb.)
Page Start:
304
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗